(2R,3R,4S,5S,6R)-2-hex-3-enoxy-6-(hydroxymethyl)oxane-3,4,5-triol

Details

Top
Internal ID e52a1870-2b81-447c-871b-03b580315424
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name (2R,3R,4S,5S,6R)-2-hex-3-enoxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CCC=CCCOC1C(C(C(C(O1)CO)O)O)O
SMILES (Isomeric) CCC=CCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
InChI InChI=1S/C12H22O6/c1-2-3-4-5-6-17-12-11(16)10(15)9(14)8(7-13)18-12/h3-4,8-16H,2,5-7H2,1H3/t8-,9-,10+,11-,12-/m1/s1
InChI Key OZIPFYKAIOOVEJ-RMPHRYRLSA-N
Popularity 5 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H22O6
Molecular Weight 262.30 g/mol
Exact Mass 262.14163842 g/mol
Topological Polar Surface Area (TPSA) 99.40 Ų
XlogP -0.40
Atomic LogP (AlogP) -0.84
H-Bond Acceptor 6
H-Bond Donor 4
Rotatable Bonds 6

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,4S,5S,6R)-2-hex-3-enoxy-6-(hydroxymethyl)oxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8273 82.73%
Caco-2 - 0.8131 81.31%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.8113 81.13%
OATP2B1 inhibitior - 0.8564 85.64%
OATP1B1 inhibitior + 0.8509 85.09%
OATP1B3 inhibitior + 0.9420 94.20%
MATE1 inhibitior - 0.9612 96.12%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior - 0.9363 93.63%
P-glycoprotein inhibitior - 0.9473 94.73%
P-glycoprotein substrate - 0.9709 97.09%
CYP3A4 substrate - 0.5248 52.48%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8327 83.27%
CYP3A4 inhibition - 0.9429 94.29%
CYP2C9 inhibition - 0.9066 90.66%
CYP2C19 inhibition - 0.7778 77.78%
CYP2D6 inhibition - 0.9147 91.47%
CYP1A2 inhibition - 0.8859 88.59%
CYP2C8 inhibition - 0.8671 86.71%
CYP inhibitory promiscuity - 0.8809 88.09%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.7159 71.59%
Eye corrosion - 0.9870 98.70%
Eye irritation - 0.9693 96.93%
Skin irritation - 0.8182 81.82%
Skin corrosion - 0.9669 96.69%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5296 52.96%
Micronuclear - 0.9500 95.00%
Hepatotoxicity - 0.8790 87.90%
skin sensitisation - 0.8722 87.22%
Respiratory toxicity - 0.7889 78.89%
Reproductive toxicity - 0.7111 71.11%
Mitochondrial toxicity - 0.7250 72.50%
Nephrotoxicity - 0.6336 63.36%
Acute Oral Toxicity (c) III 0.5313 53.13%
Estrogen receptor binding - 0.8516 85.16%
Androgen receptor binding - 0.7195 71.95%
Thyroid receptor binding - 0.5609 56.09%
Glucocorticoid receptor binding - 0.6190 61.90%
Aromatase binding - 0.7724 77.24%
PPAR gamma + 0.5305 53.05%
Honey bee toxicity - 0.8656 86.56%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.8500 85.00%
Fish aquatic toxicity - 0.4692 46.92%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.10% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.64% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 89.84% 99.17%
CHEMBL218 P21554 Cannabinoid CB1 receptor 89.26% 96.61%
CHEMBL226 P30542 Adenosine A1 receptor 86.23% 95.93%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.32% 97.25%
CHEMBL3401 O75469 Pregnane X receptor 84.13% 94.73%
CHEMBL2581 P07339 Cathepsin D 82.39% 98.95%
CHEMBL3589 P55263 Adenosine kinase 80.74% 98.05%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.31% 97.09%

Cross-Links

Top
PubChem 125625
NPASS NPC111618
LOTUS LTS0046688
wikiData Q105203846